ABSTRACT
This presentation introduces clinical aspects of hormone resistance through a number of case studies that illustrate how molecular defects at various steps in hormone production, signaling, or responsiveness can produce disease in humans. The presentation also shows how careful phenotyping of such patients has triggered decades of translational research.
Subject(s)
Endocrine System Diseases/physiopathology , Hormones/physiology , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/deficiency , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Adolescent , Alopecia/genetics , Aquaporin 2/deficiency , Aquaporin 2/genetics , Calcium/therapeutic use , Child , Child, Preschool , Disorder of Sex Development, 46,XY/enzymology , Disorder of Sex Development, 46,XY/genetics , Endocrine System Diseases/genetics , Female , Fibrous Dysplasia, Polyostotic/genetics , Humans , Male , Mutation , Phenotype , Pseudohypoparathyroidism , Receptor, Parathyroid Hormone, Type 1/deficiency , Receptor, Parathyroid Hormone, Type 1/genetics , Receptors, Calcitriol/deficiency , Receptors, Calcitriol/genetics , Rickets/classification , Rickets/genetics , Vitamin D/metabolism , Vitamin D/therapeutic useABSTRACT
Rickets is a disease of the hypertrophic chondrocytes in the growth plate and is caused by hypophosphatemia-a derived defect in terminal chondrocyte apoptosis. This highlights the critical role of phosphorous in cartilage and bone metabolism. This review shows the role of phosphorous metabolism, transport and function in maintaining phosphorous supply to the growth plate, bone osteoblast and the kidney. Given that phosphorous is the common denominator of all rickets, this review proposes a new classification for the differential diagnosis of rickets, which is based on the mechanisms leading to hypophosphatemia-high PTH activity, high FGF23 activity or renal phosphaturia.
Subject(s)
Hypophosphatemia/complications , Rickets/etiology , Animals , Fibroblast Growth Factor-23 , Fibroblast Growth Factors/blood , Fibroblast Growth Factors/metabolism , Humans , Hypophosphatemia/metabolism , Kidney Diseases/complications , Kidney Diseases/metabolism , Models, Biological , Parathyroid Hormone/blood , Parathyroid Hormone/metabolism , Phosphates/blood , Phosphates/metabolism , Rickets/classification , Rickets/diagnosis , Rickets/metabolismSubject(s)
Rickets , 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/genetics , Animals , Calcitriol/administration & dosage , Humans , Hydroxycholecalciferols/administration & dosage , Mutation , Receptors, Calcitriol/genetics , Rickets/classification , Rickets/diagnosis , Rickets/drug therapy , Rickets/geneticsABSTRACT
Radiographic changes of rickets are well characterized, but no method of grading the severity of these changes has been in general use. Consequently, it is difficult to compare objectively or follow radiographic improvement. We prospectively evaluated the utility and reproducibility of a scoring method for measuring the severity of rickets. A 10-point score for radiographs of wrists and knees was devised to assess the degree of metaphyseal fraying and cupping and the proportion of the growth plate affected. The score progresses in half point increments from zero (normal) to 10 points (severe). Four trained physicians independently scored radiographs on two separate occasions from 67 children with active rickets. A broad representation of mean radiographic scores was moderately correlated with alkaline phosphatase (r = 0.58). Interobserver correlation of radiographic scores was 0.84 or greater for all observer pairs and intraobserver correlation was 0.89 or greater for each observer. Researchers and clinicians should find the score useful to assess objectively the severity of rickets.
Subject(s)
Rickets/diagnostic imaging , Alkaline Phosphatase/metabolism , Child, Preschool , Humans , Knee Joint/diagnostic imaging , Observer Variation , Prospective Studies , Radiography , Rickets/classification , Severity of Illness Index , Wrist Joint/diagnostic imagingABSTRACT
Dietary deficiency of vitamin D, genetic disorders of its bioactivation to 1,25-dihydroxyvitamin D [1,25(OH)2D], or disorders of vitamin D action can cause rickets. The rate-limiting, hormonally-regulated, biologically activating step in the synthesis of 1,25(OH)2D is the 1 alpha-hydroxylation of 25-hydroxyvitamin D, which occurs in kidney and other tissues and is mediated by a mitochondrial cytochrome P450 enzyme, P450c1 alpha. After many years of effort, the cDNA and gene for this enzyme were cloned in late 1997. Mutations in the P450c1 alpha gene, located on chromosome 12, cause 1 alpha-hydroxylase deficiency, also known as vitamin D-dependent rickets type I, an autosomal recessive disease characterized by rickets and impaired growth due to failure of renal synthesis of 1,25(OH)2D. X-linked hypophosphatemic rickets, a dominantly inherited disease, is caused by mutations in the PHEX gene, whose function in regulating renal phosphate and vitamin D metabolism remains to be elucidated.